Opportunity to Use Artificial Intelligence in Medicine DOI Open Access
Nada Pop‐Jordanova

PRILOZI, Год журнала: 2024, Номер 45(2), С. 5 - 13

Опубликована: Июнь 1, 2024

Over the past period different reports related to artificial intelligence (AI) and machine learning used in everyday life have been growing intensely. However, AI our country is still very limited, especially field of medicine. The aim this article give some review about medicine fields based on published articles PubMed Psych Net. A research showed more than 9 thousand available at mentioned databases. After providing historical data, applications are discussed. Finally, limitations ethical implications

Язык: Английский

A systematic review of the impact of artificial intelligence on educational outcomes in health professions education DOI Creative Commons
Eva Feigerlová,

Hind Hani,

Ellie Hothersall-Davies

и другие.

BMC Medical Education, Год журнала: 2025, Номер 25(1)

Опубликована: Янв. 27, 2025

Язык: Английский

Процитировано

4

Potential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses DOI Creative Commons
Xufei Luo,

Fengxian Chen,

Di Zhu

и другие.

Journal of Medical Internet Research, Год журнала: 2024, Номер 26, С. e56780 - e56780

Опубликована: Май 31, 2024

Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In process conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing literature search, document screening, information extraction, and refinement, thereby conserving resources enhancing efficiency. However, when using LLMs, attention should paid transparent reporting, distinguishing between genuine false content, avoiding academic misconduct. this viewpoint, we highlight potential roles LLMs creation reviews meta-analyses, elucidating their advantages, limitations, future research directions, aiming provide insights guidance for authors planning meta-analyses.

Язык: Английский

Процитировано

9

ChatGPT-4o can serve as the second rater for data extraction in systematic reviews DOI Creative Commons

M. Jensen,

Mathias Brix Danielsen,

Johannes Riis

и другие.

PLoS ONE, Год журнала: 2025, Номер 20(1), С. e0313401 - e0313401

Опубликована: Янв. 7, 2025

Background Systematic reviews provide clarity of a bulk evidence and support the transfer knowledge from clinical trials to guidelines. Yet, they are time-consuming. Artificial intelligence (AI), like ChatGPT-4o, may streamline processes data extraction, but its efficacy requires validation. Objective This study aims (1) evaluate validity ChatGPT-4o for extraction compared human reviewers, (2) test reproducibility ChatGPT-4o’s extraction. Methods We conducted comparative using papers an ongoing systematic review on exercise reduce fall risk. Data extracted by were reference standard: two independent reviewers. The was assessed categorizing into five categories ranging completely correct false data. Reproducibility evaluated comparing in separate sessions different accounts. Results total 484 points across 11 papers. AI’s 92.4% accurate (95% CI: 89.5% 94.5%) produced 5.2% cases 3.4% 7.4%). between high, with overall agreement 94.1%. decreased when information not reported papers, 77.2%. Conclusion Validity high reviews. qualified as second reviewer showed potential future advancements summarizing

Язык: Английский

Процитировано

1

Celebrating 100 Years of Publishing Research in Otolaryngology–Head and Neck Surgery DOI
Jay F. Piccirillo

JAMA Otolaryngology–Head & Neck Surgery, Год журнала: 2025, Номер unknown

Опубликована: Янв. 30, 2025

This year, JAMA Otolaryngology–Head & Neck Surgery celebrates its 100th year of continuous publication. As we celebrate 100 years publication, look back on our journey, from modest beginnings to being a valued contributor medical knowledge.

Язык: Английский

Процитировано

1

Impact of artificial intelligence on future clinical pharmacy research and scholarship DOI Creative Commons
Alexandre Chan, William L. Baker, Daniel T. Abazia

и другие.

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Год журнала: 2025, Номер unknown

Опубликована: Фев. 13, 2025

Abstract Almost every facet of modern biomedical research involves artificial intelligence (AI). This ACCP commentary forecasts the role AI in clinical pharmacy and scholarship. The potential benefits/opportunities together with limitations/challenges are reviewed for stages scientific method including (1) developing question(s), study design, execution; (2) data analysis; (3) reporting dissemination research. Benefits opportunities include streamlining hypothesis generation facilitating overcoming limitations traditional statistical analysis techniques, manuscript development dissemination, expediting peer review. Limitations challenges introduction biases subject recruitment; false information, also known as “AI hallucinations”; concern “black box” analyses that difficult to validate; legal liabilities; lack accountability; need investigators ensure accuracy integrity AI‐generated content. In summary, rapid progress capabilities has great revolutionize accelerate scholarship; however, it is imperative recognize mitigate introduced by AI.

Язык: Английский

Процитировано

1

Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care DOI Creative Commons
Arya Aminorroaya, Dhruva Biswas, Aline F Pedroso

и другие.

Journal of the Society for Cardiovascular Angiography & Interventions, Год журнала: 2025, Номер 4(3), С. 102562 - 102562

Опубликована: Март 1, 2025

Artificial intelligence (AI) serves as a powerful tool that can revolutionize how personalized, patient-focused care is provided within interventional cardiology. Specifically, AI augment clinical across the spectrum for acute coronary syndrome, artery disease, and valvular heart with applications in structural interventions. This has been enabled by potential of to harness various types health data. We review AI-driven technologies advance diagnosis, preprocedural planning, intraprocedural guidance, prognostication automates tasks, increases efficiency, improves reliability accuracy, individualizes care, establishing its transform care. Furthermore, AI-enabled, community-based screening programs are yet be implemented leverage full improve patient outcomes. However, practice, tools require robust transparent development processes, consistent performance settings populations, positive impact on quality outcomes, seamless integration into workflows. Once these established, reshape cardiology, improving precision,

Язык: Английский

Процитировано

1

Implementation of a national AI technology program on cardiovascular outcomes and the health system DOI Creative Commons
Timothy Fairbairn, Liam Mullen, Edward Nicol

и другие.

Nature Medicine, Год журнала: 2025, Номер unknown

Опубликована: Апрель 4, 2025

Abstract Coronary artery disease (CAD) is a major cause of ill health and death worldwide. computed tomographic angiography (CCTA) the first-line investigation to detect CAD in symptomatic patients. This diagnostic approach risks greater second-line heart tests treatments at cost patient system. The National Health Service funded use an artificial intelligence (AI) tool, tomography (CT)-derived fractional flow reserve (FFR-CT), patients with chest pain improve physician decision-making reduce downstream tests. observational cohort study assessed impact FFR-CT on cardiovascular outcomes by including all investigated CCTA during national AI implementation program 27 hospitals (CCTA n = 90,553 7,863). was safe, no difference all-cause ( 1,134 (3.2%) versus 1,612 (2.9%), adjusted-hazard ratio (aHR) 1.00 (0.93–1.08), P 0.97) or mortality 465 (1.3%) 617 (1.1%), aHR 0.96 (0.85–1.08), 0.48), while reducing invasive coronary angiograms 5,720 (16%) 8,183 (14.9%), 0.93 (0.90–0.97), < 0.001) noninvasive cardiac (189/1,000 167/1,000), 0.001). Implementation AI-diagnostic tool as part intervention safe beneficial pathway system fewer 2 years.

Язык: Английский

Процитировано

1

Reporting Guidelines for Artificial Intelligence Studies in Healthcare (for Both Conventional and Large Language Models): What’s New in 2024 DOI
Seong Ho Park, Chong Hyun Suh

Korean Journal of Radiology, Год журнала: 2024, Номер 25(8), С. 687 - 687

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

5

Reviewer Experience Detecting and Judging Human Versus Artificial Intelligence Content: The Stroke Journal Essay Contest DOI
Gisele Sampaio Silva, Rohan Khera, Lee H. Schwamm

и другие.

Stroke, Год журнала: 2024, Номер 55(10), С. 2573 - 2578

Опубликована: Сен. 3, 2024

Artificial intelligence (AI) large language models (LLMs) now produce human-like general text and images. LLMs' ability to generate persuasive scientific essays that undergo evaluation under traditional peer review has not been systematically studied. To measure perceptions of quality the nature authorship, we conducted a competitive essay contest in 2024 with both human AI participants. Human authors 4 distinct LLMs generated on controversial topics stroke care outcomes research. A panel

Язык: Английский

Процитировано

5

Generative Artificial Intelligence in Surgical Publishing DOI
Ben Li, Ahmed Kayssi, Lianne McLean

и другие.

JAMA Surgery, Год журнала: 2025, Номер unknown

Опубликована: Фев. 5, 2025

This Viewpoint discusses the role of generative artificial intelligence in surgical publishing, including idea generation, study conduct, manuscript preparation, and review.

Язык: Английский

Процитировано

0